Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cubresa
Winnipeg, Manitoba, Canada
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Cubresa's BrainPET and NuPET imaging inserts enable high-resolution PET/MRI for both clinical and preclinical neuroscience and disease research; initial installations at major research institutes, ongoing studies in neurology and infectious disease, no commercial clinical results published yet[1][2][3].
- Therapeutic areas
- CardiovascularInfectious DiseasesOncologyNeurology
- Modalities
- Device
- Industry
- Medical Imaging
02
Partnerships
Siemens Healthineers (global master interface agreement for BrainPET: signed Feb 2025)[1]Research institutions: Lawson Health Research Institute, St. Joseph’s Health Care London, Athinoula A. Martinos Center/Massachusetts General Hospital, McGill University Neuro[1][2][3]
Beyond the preview
Go deeper on Cubresa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cubresa.